🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the value of 68Ga-Pentixafor PET/CT in the diagnosis of primary...
Status
Completed
Location
The First Affilated Hospital of Chongqing Medical University
Start Date
2021-11-11
Trial ID
NCT05131061
Treatments Being Tested
The objective of this observational study is to utilize the advantages of 6...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06756737
This will be an open, single-arm, international, multicentre, phase II imag...
Status
Terminated
Location
University Hospital Aalborg
Start Date
2022-10-05
Trial ID
NCT05222269
Treatments Being Tested
Primary aldosteronism is the most common cause of secondary hypertension. T...
Status
Recruiting
Location
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Start Date
2020-09-01
Trial ID
NCT05188872
Treatments Being Tested
Chemokine receptor CXCR4 is normally expressed on T-lymphocytes, B-lymphocy...
Status
Recruiting
Location
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Start Date
2020-08-07
Trial ID
NCT04504526
Treatments Being Tested
The goal of this clinical trial is to evaluate the effectiveness of CXCR4 t...
Status
Unknown
Location
Zhongnan Hospital of Wuhan University
Start Date
2023-05-30
Trial ID
NCT05839483
Treatments Being Tested
Chemokine receptor CXCR4 was expressed in T cells and CXCR4-targeting molec...
Status
Unknown
Location
Peking Union Medical College Hospitall, Chinese Academy of Medical Science and Peking Union Medical College
Start Date
2023-06-22
Trial ID
NCT06086327
Treatments Being Tested
To validate the accuracy of 68Ga-Pentixafor PET/CT and adrenal venous sampl...
Status
Recruiting
Location
The First Affilated Hospital of Chongqing Medical University
Start Date
2024-08-01
Trial ID
NCT06833437
Treatments Being Tested
The goal of this observational study is to evaluate the diagnostic accuracy...
Status
Recruiting
Location
Peking University First Hospital, Beijing
Start Date
2025-12-01
Trial ID
NCT07605156
Chemokine receptor CXCR4 was expressed in MM and lymphoma cells and CXCR4-t...
Status
Unknown
Location
Department of Nuclear Medicine, Peking Union Medical College Hopital, Chinese Academy of Medical Science
Start Date
2019-06-01
Trial ID
NCT03436342
Treatments Being Tested